WallStreetZenWallStreetZen

NYSE: EHAB
Enhabit Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for EHAB

Based on 1 analyst offering 12 month price targets for Enhabit Inc

Min Forecast
$8.50+15.02%
Avg Forecast
$8.50+15.02%
Max Forecast
$8.50+15.02%

Should I buy or sell EHAB stock?

Based on 1 analyst offering ratings for Enhabit Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EHAB stock forecasts and price targets.

EHAB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-08

1 of 1

Forecast return on equity

Is EHAB forecast to generate an efficient return?

Company
3.08%
Industry
-98.75%
Market
-47.34%
EHAB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EHAB forecast to generate an efficient return on assets?

Company
1.35%
Industry
10.81%
EHAB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EHAB earnings per share forecast

What is EHAB's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$0.49
Avg 2 year Forecast
$0.49
Avg 3 year Forecast
$0.52

EHAB revenue forecast

What is EHAB's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$1.1B+3.07%
Avg 2 year Forecast
$1.1B+7.69%
Avg 3 year Forecast
$1.2B+12.47%
EHAB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EHAB revenue growth forecast

How is EHAB forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
3.98%
Industry
4.44%
Market
10.97%
EHAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EHAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EHAB vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
EHAB$7.57$8.50+12.29%Hold
TOI$4.10$6.00+46.34%Strong Buy
CYH$2.77$3.74+35.09%Hold
CMPS$4.29$18.00+319.58%Strong Buy
CCRN$13.11$17.56+33.91%Hold
View Top Medical Care Facility Stocks

Enhabit Stock Forecast FAQ

Is Enhabit Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: EHAB) stock is to Hold EHAB stock.

Out of 1 analyst, 0 (0%) are recommending EHAB as a Strong Buy, 0 (0%) are recommending EHAB as a Buy, 1 (100%) are recommending EHAB as a Hold, 0 (0%) are recommending EHAB as a Sell, and 0 (0%) are recommending EHAB as a Strong Sell.

If you're new to stock investing, here's how to buy Enhabit stock.

What is EHAB's earnings growth forecast for 2025-2027?

(NYSE: EHAB) Enhabit's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 10.09%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.21%.

Enhabit's earnings in 2025 is -$138,600,000.On average, 2 Wall Street analysts forecast EHAB's earnings for 2025 to be $24,559,147, with the lowest EHAB earnings forecast at $23,799,586, and the highest EHAB earnings forecast at $25,318,709. On average, 3 Wall Street analysts forecast EHAB's earnings for 2026 to be $24,979,438, with the lowest EHAB earnings forecast at $22,280,463, and the highest EHAB earnings forecast at $26,331,457.

In 2027, EHAB is forecast to generate $26,078,270 in earnings, with the lowest earnings forecast at $22,786,838 and the highest earnings forecast at $29,369,702.

What is EHAB's revenue growth forecast for 2025-2027?

(NYSE: EHAB) Enhabit's forecast annual revenue growth rate of 3.98% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.97%.

Enhabit's revenue in 2025 is $1,032,300,000.On average, 3 Wall Street analysts forecast EHAB's revenue for 2025 to be $53,875,831,729, with the lowest EHAB revenue forecast at $53,802,255,563, and the highest EHAB revenue forecast at $54,009,868,972. On average, 3 Wall Street analysts forecast EHAB's revenue for 2026 to be $56,290,882,058, with the lowest EHAB revenue forecast at $55,495,570,787, and the highest EHAB revenue forecast at $56,825,309,357.

In 2027, EHAB is forecast to generate $58,789,028,389 in revenue, with the lowest revenue forecast at $57,390,422,931 and the highest revenue forecast at $60,187,633,846.

What is EHAB's forecast return on assets (ROA) for 2025-2028?

(NYSE: EHAB) forecast ROA is 1.35%, which is lower than the forecast US Medical Care Facilities industry average of 10.81%.

What is EHAB's Price Target?

According to 1 Wall Street analyst that have issued a 1 year EHAB price target, the average EHAB price target is $8.50, with the highest EHAB stock price forecast at $8.50 and the lowest EHAB stock price forecast at $8.50.

The Wall Street analyst predicted that Enhabit's share price could reach $8.50 by Aug 8, 2026. The average Enhabit stock price prediction forecasts a potential upside of 12.29% from the current EHAB share price of $7.57.

What is EHAB's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: EHAB) Enhabit's current Earnings Per Share (EPS) is -$2.76. On average, analysts forecast that EHAB's EPS will be $0.49 for 2025, with the lowest EPS forecast at $0.47, and the highest EPS forecast at $0.50. On average, analysts forecast that EHAB's EPS will be $0.49 for 2026, with the lowest EPS forecast at $0.44, and the highest EPS forecast at $0.52. In 2027, EHAB's EPS is forecast to hit $0.52 (min: $0.45, max: $0.58).

What is EHAB's forecast return on equity (ROE) for 2025-2028?

(NYSE: EHAB) forecast ROE is 3.08%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.